Vaccine research and development to advance pandemic and seasonal influenza preparedness and response: [electronic resource] : lessons from COVID-19

상세정보

자료유형	단행본
서명/저자사항	Vaccine research and development to advance pandemic and seasonal influenza preparedness and response: [electronic resource]: lessons from COVID-19 / Hoda Soltani, Kanta Subbarao, Enriqueta Bond editors ; Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response. Board on Global Health, Health and Medicine Division.
개인저자	Soltani, Hoda, editor. Subbarao, Kanta, editor. Bond, Enriqueta C., editor.
단체저자명	National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response,issuing body.
발행사항	Washington, DC: National Academies Press, [2022]
형태사항	1 online resource (1 PDF file (xxiii, 153 pages)) : illustrations, color maps, charts.
총서사항	Consensus study report
기타형태 저록	Print version: Medicine, National Academy of Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response Washington, D.C. : National Academies Press,c2022 9780309087810
ISBN	9780309087827 0309087821
서지주기	Includes bibliographical references.
내용주기	Front Matter -- Summary -- 1. Introduction -- 2. Basic and Translational Science -- 3. Clinical Science -- 4. Manufacturing Science -- 5. Regulatory Science -- 6. A Blueprint for Action -- Appendix A: Committee Biographies -- Appendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Staff and Consultant Biographies -- Appendix D: Public Meeting Agendas.
요약	The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.
기금정보주기	This activity was supported by a contract between the National Academy of Sciences and the Office of Global Affairs with the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
주제명(지명)	United States
일반주제명	COVID-19 (Disease) Influenza vaccines. COVID-19 vaccines. Influenza, Human --prevention & control Influenza Vaccines COVID-19 --prevention & control COVID-19 Vaccines Vaccine Development COVID-19 COVID-19. Vaccins antigrippaux. Vaccins contre la COVID-19. COVID-19 (Disease) Influenza vaccines
분류기호(NLMC)	WC 515
분류기호(DDC)	625.7 s 625.85
언어	영어
바로가기